# EDGAR Filing Document

**Accession Number:** 0001723980
**File Stem:** 9999999995-25-003288
**Filing Date:** 2025-11
**Character Count:** 1386
**Document Hash:** c2f106f3949e42d4679ae9858feb6381
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**9999999995-25-003288.hdr.sgml**: 20251117

**ACCESSION NUMBER**: 9999999995-25-003288

**CONFORMED SUBMISSION TYPE**: EFFECT

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20251114

**DATE AS OF CHANGE**: 20251117

**EFFECTIVENESS DATE**: 20251114

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** China SXT Pharmaceuticals, Inc.
- **CENTRAL INDEX KEY:** 0001723980
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** D8
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** EFFECT
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-282776
- **FILM NUMBER:** 251489161

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 178 TAIDONG ROAD NORTH
- **CITY:** TAIZHOU
- **PROVINCE COUNTRY:** F4
- **BUSINESS PHONE:** 8652386298290

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 178 TAIDONG ROAD NORTH
- **CITY:** TAIZHOU
- **PROVINCE COUNTRY:** F4

### UNITED STATES
### SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## Notice of Effectiveness

**Date:** November 14, 2025

**Accession Number:** 0001213900-25-108213

**Form Type:** POS AM

---

**CIK:** 0001723980

**Company Name:** China SXT Pharmaceuticals, Inc.

**File Number:** 333-282776